Aggregation framework for continuous digital health measures and application to walking activity data
Abstract
Abstract No standardized procedures for aggregating continuous digital health measures exist. Using a modified Delphi approach, we developed a framework to standardize the selection of aggregations that provide clinically meaningful, stable values. This was applied to aggregate seven digital mobility outcomes (DMOs:walking bout (WB) duration, step count, walking speed, stride length, cadence, stride duration, and number of WBs), collected over 7 days, in 2181 individuals with and without mobility disabilities. We defined aggregations as combinations of restrictions (data segments) and summary statistics, and developed a three-part framework. In Part 1, candidate restriction–summary statistic combinations are identified considering technical validity, interpretability, sample size, and distribution. Part 2 assesses within-participant stability with intraclass correlation coefficients (ICCs), and discriminant capacity between healthy and mobility disabilities with the area under the curve (AUC) on as many temporal levels as needed. Part 3 involves expert discussions combining subject-specific experience, guidelines, and data-driven results to select final aggregation(s). Applied to DMOs, we identified candidate aggregations (Part 1), found moderate-to-high daily ICCs (range 0.45–1.00) and varying AUCs (range 0.43–0.90) (Part 2), and finally selected 24 daily- and weekly-aggregated DMOs, classified into walking activity and gait DMOs (Part 3). In summary, reducing digital health data into clinically meaningful, statistically stable values is achievable with standardized procedures.
// Source
Authors: Sarah Koch, Joren Buekers, Paula Alvarez-Riu, Clemens Becker, Tecla Bonci, Anne‐Elie Carsin, Brian Caulfield, Inés Cobo, Silvia Del Din, Heleen Demeyer, Anja Frei, Jeffrey M. Hausdorff, Anisoara Ionescu, Kamiar Aminian, Jochen Klenk, Jorge Lemos-Portela, Jose Marchena, Walter Maetzler, Encarna Micó-Amigo, Paolo Piraino, David Singleton, Oleksandr Sverdlov, Thierry Troosters, Lynn Rochester, Judith Garcia-Aymerich
Institutions: University of Basel, KU Leuven, Ghent University, Bayer (Germany), Barcelona Institute for Global Health, University of Zurich, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, University of Lübeck, Newcastle University, Heriot-Watt University, University Hospital Schleswig-Holstein, Universitat Pompeu Fabra, University College Dublin, Newcastle upon Tyne Hospitals NHS Foundation Trust, École Polytechnique Fédérale de Lausanne, Universität Ulm, Tel Aviv Sourasky Medical Center, Rush University Medical Center, Zimmer Biomet (Germany), Christian-Albrechts-Universität zu Kiel, Robert Bosch Hospital, VIB-KU Leuven Center for Microbiology, NIHR Newcastle Biomedical Research Centre, Insigneo, Novartis (United States)